Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 21Rectal Neoplasms 18Colonic Neoplasms 18Stomach Neoplasms 13Gastrointestinal Stromal Tumors 5Carcinoma, Hepatocellular 5Pancreatic Neoplasms 3Liver Neoplasms 3Peritoneal Neoplasms 2Neoplastic Cells, Circulating 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Urinary Incontinence 1Surgical Wound Infection 1Sexual Dysfunction, Physiological 1Robotic 1Pancreatic Neuroendocrine Tumors 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lymphatic Metastasis 1Locally Advanced Pancreatic Adenocarcinoma 1Locally Advanced Gastric Cancer 1Liver Diseases 1Kidney Neoplasms 1Inflammatory Bowel Diseases 1Genital Neoplasms, Female 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1

Interventions

pembrolizumab 1nilotinib 1lenvatinib 1Standard of Care 1Radiotherapy 1Practice Guidelines as Topic 1Paclitaxel 1Moxibustion 1Methods 1Laparoscopy 1Electrocardiography 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genital Neoplasms, Female × Laparoscopy × Gastrointestinal × Clear all
NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡